Abiopharma

CERIBELL, INC. (CBLL)

Symbol	CBLL
Name	CERIBELL, INC.
Sector	HEALTH CARE
Region	North America
Industry	Biotechnology: Electromedical & Electrotherapeutic Apparatus
Address	360 N. PASTORIA AVENUE, SUNNYVALE, California, 94085, United States
Telephone	+1 800 436-0826
Fax	—
Email	—
Website	https://www.ceribell.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001861107
Description	CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. We are initially focused on becoming the standard of care for the detection and management of seizures in the acute care setting. The Ceribell System has been adopted by more than 450 active accounts, ranging from top academic centers to small community hospitals, and has been used to care for over 100,000 patients. Additional info from NASDAQ: CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. We are initially focused on becoming the standard of care for the detection and management of seizures in the acute care setting. The Ceribell System has been adopted by more than 450 active accounts, ranging from top academic centers to small community hospitals, and has been used to care for over 100,000 patients.

2026-09-11 00:27

Foehr David 🟡 adjusted position in 9.3K shares (1 derivative) of Ceribell, Inc. (CBLL) at $24.26 Transaction Date: Sep 08, 2026 | Filing ID: 388299

2026-09-11 00:23

Woo Raymond 🟡 adjusted position in 4.9K shares (3 derivative) of Ceribell, Inc. (CBLL) at $24.33 Transaction Date: Sep 08, 2026 | Filing ID: 388295

2026-09-08 17:23

📋 Foehr David (Officer) plans to sell 9K shares of Ceribell, Inc. (at $24.33 each, total $225K) Filed: Sep 08, 2026 | ID: 006785

2026-09-08 13:42

📋 Woo Raymond (Officer) plans to sell 5K shares of Ceribell, Inc. (at $24.33 each, total $119K) Filed: Sep 08, 2026 | ID: 006771

2026-09-04 22:13

Chao Xingjuan 🟡 adjusted position in 39.5K shares (2 derivative) of Ceribell, Inc. (CBLL) at $24.61 ($1.2M) Transaction Date: Sep 02, 2026 | Filing ID: 383893

2026-09-04 22:12

Blumberg Scott 🟡 adjusted position in 652 shares (1 derivative) of Ceribell, Inc. (CBLL) at $25.00 Transaction Date: Sep 02, 2026 | Filing ID: 383891

2026-09-02 20:59

📋 Chao Xingjuan (Officer) plans to sell 40K shares of Ceribell, Inc. (at $24.61 each, total $973K) Filed: Sep 02, 2026 | ID: 006675

2026-09-02 20:38

📋 Blumberg Scott (Officer) plans to sell 652 shares of Ceribell, Inc. (at $25.00 each, total $16K) Filed: Sep 02, 2026 | ID: 006672

2026-08-25 23:29

Manni Joseph S. 🔴 sold 1.4K shares of Ceribell, Inc. (CBLL) at $24.02 Transaction Date: Aug 21, 2026 | Filing ID: 365558

2026-08-25 23:27

Foehr David 🔴 sold 1.9K shares of Ceribell, Inc. (CBLL) at $24.02 Transaction Date: Aug 21, 2026 | Filing ID: 365554

Trial ID	Title	Phase	Indication	Status	Start Date	Completion Date	Source
NCT07485244	EEG Abnormalities in Adult ICU Patients With High Risk of Delirium	—	Delirium in the Intensive Care Unit	Recruiting	2026-04-16	2027-09-30	ClinicalTrials.gov
NCT07449416	Ceribell Delirium Monitor Outcomes Pilot Study	Na	Delirium in the Intensive Care Unit	Recruiting	2026-03-15	2026-12-01	ClinicalTrials.gov

Total clinical trials: 2

Product Name	Type	Development Stage	Therapeutic Area	Study Status	Trial ID
Ceribell Delirium Monitoring System	Other	Approved	Delirium in the Intensive Care Unit	RECRUITING	NCT07449416
Ceribell Delirium Monitoring System	Other	Approved	Delirium in the Intensive Care Unit	NOT_YET_RECRUITING	NCT07449416
Ceribell EEG System	Other	Preclinical	Delirium in the Intensive Care Unit	RECRUITING	NCT07485244
Ceribell EEG System	Other	Preclinical	Delirium in the Intensive Care Unit	RECRUITING	NCT07485244
Ceribell EEG System	Other	Preclinical	Delirium in the Intensive Care Unit	RECRUITING	NCT07485244
Ceribell EEG System	Other	Preclinical	Delirium in the Intensive Care Unit	RECRUITING	NCT07485244
Ceribell EEG System	Other	Preclinical	Delirium in the Intensive Care Unit	RECRUITING	NCT07485244
Ceribell EEG System	Other	Preclinical	Delirium in the Intensive Care Unit	RECRUITING	NCT07485244
Ceribell EEG System	Other	Preclinical	Delirium in the Intensive Care Unit	RECRUITING	NCT07485244
Ceribell EEG System	Other	Preclinical	Delirium in the Intensive Care Unit	RECRUITING	NCT07485244
Ceribell EEG System	Other	Preclinical	Delirium in the Intensive Care Unit	RECRUITING	NCT07485244

Total products: 11